{"id":"NCT02736955","sponsor":"Neurocrine Biosciences","briefTitle":"Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia","officialTitle":"Open-Label Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-06-13","primaryCompletion":"2017-06-30","completion":"2017-06-30","firstPosted":"2016-04-13","resultsPosted":"2018-12-19","lastUpdate":"2018-12-19"},"enrollment":161,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Tardive Dyskinesia"],"interventions":[{"type":"DRUG","name":"Valbenazine","otherNames":["NBI-98854"]}],"arms":[{"label":"Valbenazine","type":"EXPERIMENTAL"}],"summary":"This Phase 3b, rollover study will provide participants who completed a Phase 3 valbenazine (NBI-98854) study open-label access to valbenazine (fixed doses administered once daily) for the treatment of adults with TD until valbenazine is anticipated to be available commercially or they complete 72 weeks of treatment. This study will allow enrollment of up to 150 medically stable male and female participants with TD who previously participated in and completed the NBI-98854-1304 (Kinect 3) or NBI-98854-1402 (Kinect 4) Phase 3 study.","primaryOutcome":{"measure":"Number of Participants Monitored for Long-term Safety of Valbenazine","timeFrame":"60 weeks","effectByArm":[{"arm":"Valbenazine 40 mg","deltaMin":35,"sd":null},{"arm":"Valbenazine 80 mg","deltaMin":117,"sd":null},{"arm":"Valbenazine 40/80 mg","deltaMin":8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":10},"locations":{"siteCount":27,"countries":["United States"]},"refs":{"pmids":["32419679"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":35},"commonTop":["Urinary tract infection","Back pain","Cough","Somnolence","Upper respiratory tract infection"]}}